Neurotar Oy Ltd

📍 Helsinki, Finland🗓 Founded 2009👥 13 employees💰 Last funded May 2015
Neurotar’s mission is to advance brain research in live animals as a more translational alternative to in vitro and ex vivo research. To this end, we provide in vivo two-photon imaging of the mouse brain as a service for global pharmaceutical and biotech companies working in the CNS area. Key focus areas are trans-BBB PK of large molecules, Alzheimer's disease, and stroke. In vivo two-photon imaging allows studying the brain longitudinally with subcellular resolution. In our second line of business, we commercialize innovative research tools (Mobile HomeCage line of products) that facilitate basic research in live and non-anesthetized mice. Mobile HomeCage products eliminate the biases associated with the use of anesthetics and allow combining high precision techniques (in vivo two-photon imaging, in vivo electrophysiology, optogenetics) with behavioral studies. The Mobile HomeCage is used by 130+ academic and industrial labs worldwide, primarily in North America and Central Europe.
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2009
Founded
Investor geography1 country
Portugal
1
Frequently asked questions
Who invested in Neurotar Oy Ltd?
Neurotar Oy Ltd has 1 investors on record on gritt.io and 1 late-stage investors.
When did Neurotar Oy Ltd last raise funding?
The most recent investment in Neurotar Oy Ltd recorded on gritt.io was in May 2015.
When was Neurotar Oy Ltd founded?
Neurotar Oy Ltd was founded in 2009.
What industry is Neurotar Oy Ltd in?
Neurotar Oy Ltd operates in Research Services. Find similar Research Services investors on gritt.io.
Where is Neurotar Oy Ltd based?
Neurotar Oy Ltd is headquartered in Helsinki, Finland.